Saturday 24 May, 2025 01:51 AM
Site map | Locate Us | Login
   Kirloskar Inds gains after Q4 PAT climbs 95% QoQ to Rs 47 cr    Shilpa Medicare zooms as arm partners with Orion Corporation    AIA Engineering gains after Q4 PAT rises 10% QoQ to Rs 285 crore    Alembic Pharma receives USFDA nod for Amlodipine and Atorvastatin Tablets    Bharti Airtel Ltd Partly Paidup leads losers in 'A' group    Dhabriya Polywood soars as Q4 PAT jumps 32% YoY to Rs 5 crore    Devyani Intl Q4 net loss widens to Rs 15 cr    Premier Explosives Ltd leads losers in 'B' group    Premier Explosives drops after weak Q4 numbers    Greenpanel Inds Q4 PAT falls 1% YoY to Rs 29 crore    Volumes spurt at Honasa Consumer Ltd counter    BEML gains as Q4 PAT jumps 12% YoY to Rs 288 cr    Healthcare shares slide    Sun Pharma drops after Q4 PAT slides 19% YoY to Rs 2,1450 cr    Mankind Pharma Ltd slips for fifth straight session 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Mankind Pharma Ltd slips for fifth straight session
23-May-25   13:35 Hrs IST

Mankind Pharma Ltd is down for a fifth straight session today. The stock is quoting at Rs 2421, down 0.75% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 1.12% on the day, quoting at 24886.2. The Sensex is at 81814.38, up 1.07%.Mankind Pharma Ltd has lost around 6.86% in last one month.Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has eased around 2.72% in last one month and is currently quoting at 21521.75, down 0.67% on the day. The volume in the stock stood at 1.15 lakh shares today, compared to the daily average of 3.47 lakh shares in last one month.

The PE of the stock is 52.01 based on TTM earnings ending December 24.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 41057592
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited